MONTREAL, April 20 /PRNewswire/ - IatroQuest Corporation, a leading developer of advanced biosensing technologies based in Montreal, Canada, is pleased to announce the appointment of Mr. Arthur L. Money to the board of directors of the company. Mr. Money brings to IatroQuest more than 40 years of management and engineering experience with the defense electronics industry and intelligence community. From 1999 to 2001, Mr. Money was Assistant Secretary of Defense for Command, Control, Communications and Intelligence for the American Government. He also served as Chief Information Officer for the Department of Defense and Assistant Secretary of the Air Force for Research, Development and Acquisition. He was also President of ESL Inc., a subsidiary of TRW that was consolidated with TRW's Avionics and Surveillance Group. "Mr. Money will provide IatroQuest with increased visibility and insight into the US government intelligence community/national security marketplace", stated John Schafer, CEO of IatroQuest. "His experience and leadership will help us better serve the needs of the biodefense market, both for military and civil defense applications, which is one of the primary markets targeted by IatroQuest for its Bio-Alloy(TM) technology." "I am enthusiastic about joining the board of a company with such an exciting technology, which can fill the critical need for biodefense in America and the world", said Art Money. IatroQuest Corporation's breakthrough, patented biosensing platform technology called Bio-Alloy(TM), can rapidly detect and identify a wide range of biological and chemical agents, without labels and with a high degree of sensitivity and selectivity. It has specific advantages over similar technologies to meet the requirements and urgent needs of the biodefense industry that is resulting from the increase in worldwide terrorism. Recently, IatroQuest Corporation announced that it has signed a deal with In-Q-Tel, a private not for profit venture capital group funded by the US Central Intelligence Agency (CIA) to enhance and customize its Bio-Alloy(TM) technology to better meet national security needs. About IatroQuest Corporation Founded in 1998 and based in Montreal, Canada, IatroQuest Corporation ( www.iatroquest.com ) is shaping the future of biosensing using a revolutionary patented technological platform called Bio-Alloy(TM), which combines biotechnology, advanced semi-conductor materials, nanotechnology and photonics. Bio-Alloy(TM) makes a wide range of products possible in several market segments, such as biodefense, life sciences research and point-of-care diagnostics. Bio-Alloy(TM) has unique characteristics that enable rapid detection and quantification, with a high degree of sensitivity and specificity without using labels, of a wide range of biological agents as well as small chemical molecules.
SOURCE IATROQUEST CORPORATION